1. S
M&A Expertise in Healthcare and Life Sciences: Top 10 Pharmaceutical Deals All-Time
&C has played a leading role in the consolidation of the pharmaceutical sector, advising on six of the ten largest pharmaceutical M&A deals to date.
Acquirer
Target
Date
Value
($ millions)
Pfizer (U.S.)
Allergan (Ireland)
2015
191,522
Warner-Lambert (U.S.)
2000
88,771
Glaxo Wellcome* (U.K.)
SmithKline Beecham (U.K.)
78,775
Actavis PLC (Ireland)
2014
66,404
Sanofi-Synthelabo (France)
Aventis* (France)
2004
65,657
Wyeth (U.S.)
2009
64,480
Pharmacia* (U.S.)
2003
60,704
Novartis (Switzerland)
Alcon* (Switzerland)
2011
50,425***
Roche Holding** (Switzerland)
Genentech (U.S.)
46,695
Merck (U.S.)
Schering-Plough** (U.S.)
45,913
Source: Thomson Reuters, December 07, 2015
* Representing the company identified
** Representing the financial adviser to the company identified
*** Aggregate value of three-step transaction ultimately consummated in 2011